This filing confirms Genoil remains a pre-revenue development-stage company with a near-zero cash balance and a going concern warning. The stock trades at sub-penny levels on the OTC. Traders should expect continued dilution via private placements and potential delisting risk if the company fails to raise capital. No catalyst for a re-rating exists without a commercial contract or technology licensing deal.
Price Chart
Executive Summary
Genoil Inc. filed its annual 20-F for FY2025, reporting zero revenue, a net loss of $640,501 (improved from a $2.09M loss in 2024), and a going concern qualification from its auditor. The company has only $12 in cash, a $508,876 stockholders' deficit, and accumulated losses of $106.6M. No technologies have been commercialized. The auditor's report includes an explanatory paragraph about substantial doubt regarding the company's ability to continue as a going concern.
Key Facts
- Zero revenue for FY2025 and FY2024; no commercial operations.
- Net loss of $640,501 in FY2025, improved from $2,086,303 in FY2024.
- Cash and cash equivalents of only $12 as of Dec 31, 2025.
- Stockholders' deficit of $508,876; accumulated deficit of $106,563,227.
- Auditor HHL LLP issued a going concern explanatory paragraph.
- Material weakness in internal controls over financial reporting identified.
- 48% potential dilution from 962.9M outstanding warrants, options, PACs, and convertible notes.
- Only $402,500 raised in private placements during FY2025.
- Related party debt to Lifschultz Enterprise Company LLC totals $220,139 in convertible notes plus $72,256 accrued interest.
- No cash compensation paid to executives; compensation is entirely share-based.
Financial Impact
Net loss of $640,501 in FY2025; cash position of $12; accumulated deficit of $106.6M.
Risk Factors
- Going concern risk — only $12 cash on hand; may not survive without additional financing.
- Extreme dilution risk — 48% potential dilution from outstanding convertible instruments.
- Material weakness in internal controls increases risk of financial misstatement.
- No revenue or commercial operations since inception; technology remains unproven.
- Heavy reliance on related-party financing from CEO-controlled entity.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 20-F Filing (Primary) | 0001654954-26-004801 |
| Document: gnolf_ex151.htm | 0001654954-26-004801 |
| Document: gnolf_ex121.htm | 0001654954-26-004801 |
| Document: gnolf_ex131.htm | 0001654954-26-004801 |
| Document: 0001654954-26-004801-index-headers.html | 0001654954-26-004801 |
| Document: 0001654954-26-004801-index.html | 0001654954-26-004801 |
| Document: 0001654954-26-004801.txt | 0001654954-26-004801 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers